Rigontec raises EUR 15M for RIG-I agonists

Rigontec GmbH (Bonn, Germany) raised EUR 15 million ($16.8 million) in the third and final close of its series A round. Existing investors Boehringer Ingelheim Venture Fund, Forbion Capital Partners, High-Tech Gruenderfonds, NRW BANK, MP Healthcare Venture Management, Sunstone Capital and Wellington Partners Life Sciences participated.

Rigontec raised a total of EUR 29.3 million in the round. The company raised EUR 9.5 million in October 2014 first close, and added EUR 4.8 million in March 2015. ...